SLG
INSP icon

Stanley-Laman Group’s Inspire Medical Systems INSP Stock Holding History

Stanley-Laman Group’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-46,025
Closed -$6.16M – 294
2024
Q2 		$6.16M Sell
46,025
-4,387
-9% -$830K 0.89% 22
2024
Q1 		$10.8M Sell
50,412
-639
-1% -$125K 1.52% 8
2023
Q4 		$10.4M Buy
+51,051
New +$8.27M 1.59% 5
2022
Q1 		– Sell
-1,302
Closed -$300K – 292
2021
Q4 		$300K Buy
+1,302
New +$318K 0.04% 238

Other funds holding INSP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Stanley-Laman Group's INSP Position: Q3 2024 in Review

Stanley-Laman Group sold out of Inspire Medical Systems (INSP) in Q3 2024, closing a stake of 46,025 shares — an estimated $6.16M sold.

Stanley-Laman Group first reported a position in INSP in Q4 2021 and held it in 4 quarters. The position peaked at $10.8M in Q1 2024. 346 funds tracked by Wall St. Rank hold INSP as of Q3 2024.

  • Stanley-Laman Group reported no remaining Inspire Medical Systems position as of Q3 2024 after selling out during the quarter.
  • Stanley-Laman Group sold 46,025 Inspire Medical Systems shares in Q3 2024, an estimated $6.16M.
  • Stanley-Laman Group first reported a position in Inspire Medical Systems in Q4 2021 and held it in 4 quarters.
  • Stanley-Laman Group's Inspire Medical Systems position peaked at $10.8M in Q1 2024.
  • 346 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2024.

Based on Stanley-Laman Group's 13F filing for Q3 2024, filed 22 Oct 2024.